SCHEMBL5494425

SCHEMBL5494425

COC1CC(N)CC(OC)C1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20776323 0.87
SCHEMBL7793301 0.85 KDM1A (0.31)
SCHEMBL20776342 0.79
SCHEMBL22084028 0.78
SCHEMBL10988854 0.74
SCHEMBL22249331 0.74
SCHEMBL22249332 0.74
SCHEMBL24497274 0.73
SCHEMBL14701161 0.73
SCHEMBL10988849 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430733-A Bimetallic catalyst based on acylhydrazone pyrene skeleton, and preparation method and application thereof 万华化学集团股份有限公司 2024-01-23 CN claimed
US-7169759-B1 Tetrapeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2007-01-30 US claimed
US-20050182138-A1 Dipeptide inhibitors of beta-secretase ELAN PHARMACEUTICALS, INC. 2005-08-18 US claimed
US-6864240-B1 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2005-03-08 US claimed
EP-1192177-A1 STATINE-DERIVED TETRAPEPTIDE INHIBITORS OF BETA-SECRETASE Elan Pharmaceuticals, Inc. (US) 2002-04-03 EP claimed
WO-2000077030-A1 STATINE-DERIVED TETRAPEPTIDE INHIBITORS OF BETA-SECRETASE ELAN PHARMACEUTICALS, INC. (US) 2000-12-21 WO claimed
CN-117430733-A Bimetallic catalyst based on acylhydrazone pyrene skeleton, and preparation method and application thereof 万华化学集团股份有限公司 2024-01-23 CN disclosed